Natera Stock (NASDAQ: NTRA) stock price, news, charts, stock research, profile.
Open | $95.880 |
Close | $96.980 |
Volume / Avg. | 1.070M / 1.364M |
Day Range | 94.980 - 97.440 |
52 Wk Range | 36.900 - 98.820 |
Market Cap | $11.839B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 5.37% |
Days to Cover | 3.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Natera (NASDAQ: NTRA) through any online brokerage.
Other companies in Natera’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Natera (NASDAQ: NTRA) was reported by Goldman Sachs on Monday, April 15, 2024. The analyst firm set a price target for 100.00 expecting NTRA to rise to within 12 months (a possible 3.25% upside). 33 analyst firms have reported ratings in the last year.
The stock price for Natera (NASDAQ: NTRA) is $96.85 last updated May 3, 2024 at 6:14 PM EDT.
There are no upcoming dividends for Natera.
Natera’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Natera.
Natera is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.